caffeine has been researched along with 15-deoxy-delta(12,14)-prostaglandin j2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, T; Gao, C; Gressner, AM; Gressner, OA; Lahme, B; Müller, T; Rehbein, K; Siluschek, M | 1 |
1 other study(ies) available for caffeine and 15-deoxy-delta(12,14)-prostaglandin j2
Article | Year |
---|---|
Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs.
Topics: Adult; Aged; Asian People; Caffeine; Connective Tissue Growth Factor; Female; Hepatocytes; Humans; Liver Cirrhosis; Male; Middle Aged; PPAR gamma; Prostaglandin D2; Up-Regulation; White People | 2009 |